ADIM
SEAT icon

Alpha DNA Investment Management’s Vivid Seats SEAT Stock Holding History

Alpha DNA Investment Management’s Portfolio SEAT Stock Details SEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,198
Closed -$531K – 239
2023
Q4 		$531K Buy
+4,198
New +$575K 0.21% 112

Other funds holding SEAT

SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Alpha DNA Investment Management's SEAT Position: Q1 2024 in Review

Alpha DNA Investment Management sold out of Vivid Seats (SEAT) in Q1 2024, closing a stake of 4,198 shares — an estimated $531K sold.

Alpha DNA Investment Management first reported a position in SEAT in Q4 2023 and held it in 1 quarter. The position peaked at $531K in Q4 2023. 133 funds tracked by Wall St. Rank hold SEAT as of Q1 2024.

  • Alpha DNA Investment Management reported no remaining Vivid Seats position as of Q1 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 4,198 Vivid Seats shares in Q1 2024, an estimated $531K.
  • Alpha DNA Investment Management first reported a position in Vivid Seats in Q4 2023 and held it in 1 quarter.
  • Alpha DNA Investment Management's Vivid Seats position peaked at $531K in Q4 2023.
  • 133 funds tracked by Wall St. Rank held Vivid Seats as of Q1 2024.

Based on Alpha DNA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.